Abiopharma

New Form 144 - iRhythm Technologies, Inc. Filed: 2025-08-11 AccNo: 0001950047-25-005613 Size: 5 KB

New Form 144 - Royalty Pharma plc Filed: 2025-08-11 AccNo: 0001964306-25-000309 Size: 4 KB

New Form 144 - BridgeBio Pharma, Inc. Filed: 2025-08-11 AccNo: 0001950047-25-005610 Size: 7 KB

New Form ARS - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-11 AccNo: 0001437749-25-025936 Size: 2 MB

New Form 10-Q - HARROW, INC. Filed: 2025-08-11 AccNo: 0001641172-25-022980 Size: 8 MB

New Form 8-K - Inspire Medical Systems, Inc. Filed: 2025-08-11 AccNo: 0001609550-25-000035 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 10-Q - TELA Bio, Inc. Filed: 2025-08-11 AccNo: 0001558370-25-011052 Size: 6 MB

New Form 8-K - Catheter Precision, Inc. Filed: 2025-08-11 AccNo: 0001437749-25-025935 Size: 206 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - NEPHROS INC Filed: 2025-08-11 AccNo: 0001641172-25-022978 Size: 458 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - BECTON DICKINSON & CO Filed: 2025-08-11 AccNo: 0000010795-25-000081 Size: 4 KB

New Form 8-K - MYOMO, INC. Filed: 2025-08-11 AccNo: 0000950170-25-106562 Size: 752 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025

Azitra, Inc. Announces Reverse Stock Split

New Form 8-K - ENANTA PHARMACEUTICALS INC Filed: 2025-08-11 AccNo: 0001193125-25-177941 Size: 452 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Climb Bio, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106563 Size: 4 KB